Martorell hypertensive ischemic leg ulcer: A model of ischemic Subcutaneous Arteriolosclerosis

Archives of Dermatology

Volumn 146, Issue 9, 2010, Pages 961-968

  Hafner, Jürg ^a   Nobbe, Stephan ^a   Partsch, Hugo ^c   Läuchli, Severin ^a   Mayer, Dieter ^b   Amann Vesti, Beatrice ^b   Speich, Ruedi ^b   Schmid, Christoph ^b   Burg, Günter ^a   French, Lars E ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c WILHELMINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTERIOLOSCLEROSIS; ARTICLE; CALCIFIC UREMIC ARTERIOLOPATHY; CALCINOSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; DEBRIDEMENT; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEG ULCER; MALE; MARTORELL HYPERTENSIVE ISCHEMIC LEG ULCER; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SEPSIS; SKIN EXAMINATION; SKIN ULCER; SPLIT THICKNESS SKIN GRAFT; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; ISCHEMIA; LEG; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NECROSIS; PAIN MEASUREMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SKIN TRANSPLANTATION; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME; VASCULARIZATION; VERY ELDERLY; WOUND HEALING;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIHYPERTENSIVE AGENTS; ARTERIOLOSCLEROSIS; CALCIPHYLAXIS; COHORT STUDIES; COMBINED MODALITY THERAPY; DEBRIDEMENT; FEMALE; HUMANS; HYPERTENSION; ISCHEMIA; LEG; LEG ULCER; MALE; MIDDLE AGED; NECROSIS; PAIN MEASUREMENT; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN TRANSPLANTATION; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME; WOUND HEALING;

EID: 77957116494     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.224     Document Type: Article

References (35)

1. Martorell F. Las ulceras supramaleolares por arteriolitis de las grandes hipertensas. Actas (Reun Cientif Cuerpo Facul) Inst Policlinico Barcelona. 1945;1(1):6-9.
2. Hines EA, Farber EM. Ulcer of the leg due to arteriosclerosis and ischemia, occurring in the presence of hypertensive disease (hypertensive- ischemic ulcers): a preliminary report. Proc Staff Meet Mayo Clin. 1946;21:337-346.
3. Farber EM, Hines EA Jr, Montgomery H, Craig W. The arterioles of the skin in essential hypertension. J Invest Dermatol. 1947;9(6):285-298.
4. Schnier BR, Sheps SG, Juergens JL. Hypertensive ischemic ulcer: a review of 40 cases. Am J Cardiol. 1966;17(4):560-565.
5. Lazareth I, Priollet P. Necrotic angiodermatitis: treatment by early cutaneous grafts [in French]. Ann Dermatol Venereol. 1995;122(9):575-578.
6. Henderson CA, Highet AS, Lane SA, Hall R. Arterial hypertension causing leg ulcers. Clin Exp Dermatol. 1995;20(2):107-114.
7. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens. 2001;15(4):279-283. (Pubitemid 32293687)
8. Hafner J, Keusch G, Wahl C, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol. 1995;33(6):954-962.
9. Hafner J, Keusch G, Wahl C, Burg G. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa. 1998;27(3):137-143.
10. Llach F. Calcific uremic arteriolopathy (calciphylaxis): an evolving entity? Am J Kidney Dis. 1998;32(3):514-518. (Pubitemid 28411229)
11. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569-579. (Pubitemid 46400180)
12. Ramsey-Stewart G. Eutrophication: spontaneous progressive dermatoliponecrosis: a fatal complication of gross morbid obesity. Obes Surg. 1992;2(3):263-264.
13. Kalajian AH, Malhotra PS, Callen JP, Parker LP. Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed. Arch Dermatol. 2009;145(4):451-458.
14. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3(4):1139-1143.
15. Conrad C, Trüeb RM. Pyoderma gangrenosum. J Dtsch Dermatol Ges. 2005;3(5):334-342.
16. Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347(18):1412-1418. (Pubitemid 35239713)
17. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-617.
18. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938-942. (Pubitemid 34258697)
19. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208-2218. (Pubitemid 39031360)
20. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71(5):438-441.
21. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112(3):357-366.
22. Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A: formation of colloidal calciprotein particles. J Biol Chem. 2003;278(15):13333-13341. (Pubitemid 36800105)
23. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386(6620):78-81. (Pubitemid 27130923)
24. Wallin R, Cain D, Sane DC. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells - a cell system which resembles the system in bone cells. Thromb Haemost. 1999;82(6):1764-1767.
25. Zutt M, Hallermann C, Gutgesell C, Bertsch HP, Neumann C. Idiopathische Calcinosis cutis mit ausgedehnten Unterschenkelulzera. Phlebologie. 2002;31(2):50-55.
26. Davis JC, Landeen JM, Levine RA. Pyoderma gangrenosum: skin grafting after preparation with hyperbaric oxygen. Plast Reconstr Surg. 1987;79(2):200-207.
27. Cliff S, Holden CA, Thomas PR, Marsden RA, Harland CC. Split skin grafts in the treatment of pyoderma gangrenosum: a report of four cases. Dermatol Surg. 1999;25(4):299-302. (Pubitemid 29191317)
28. Kaddoura IL, Amm C. A rationale for adjuvant surgical intervention in pyoderma gangrenosum. Ann Plast Surg. 2001;46(1):23-28. (Pubitemid 32050393)
29. Ghersi MM, Ricotti C, Nousari CH, Newman MI. Negative pressure dressing in the management of pyoderma gangrenosum ulcer. Arch Dermatol. 2007;143(10):1249-1251. (Pubitemid 47607692)
30. Duncan HJ, Faris IB. Martorell's hypertensive ischemic leg ulcers are secondary to an increase in the local vascular resistance. J Vasc Surg. 1985;2(4):581-584.
31. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension. 2006;48(6):1012-1017. (Pubitemid 44772698)
32. Block GA, Martin KJ, de Francisco ALM, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350(15):1516-1525.
33. Suki WN, Zabaneh R, Cangiano JL, et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007;72(9):1130-1137.
34. Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis. 2004;43(6):1104-1108. (Pubitemid 38691507)
35. Hackett BC, McAleer MA, Sheehan G, Powell FC, O'Donnell BF. Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate. Clin Exp Dermatol. 2009;34(1):39-42.